Endpoints News 生物医药· Max Bayer·· 2026-10-01AI 评分20
立法者就致幻剂资格认证意见不一
Lawmakers hear mixed opinions on psychedelics credentialing
AI 导读
随着致幻剂药物逐渐接近商业化,两名众议院立法者正在为其推广及潜在伴随立法规划路径。立法者们在致幻剂资格认证问题上持有不同意见。
正文
As psychedelic drugs inch closer to commercialization, two House lawmakers are charting a path forward for their inevitable rollout and what any potential accompanying legislation …
Sign up to read this article for free.
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.
来源:Endpoints News 生物医药 · endpoints.news